BCL3 and skin basal cell carcinoma: Bcl3's involvement in the pathogenesis of BCCs was further confirmed by our studies showing that intra-tumoral injections of a cell permeable p50 decoy peptide (DP) blocked nuclear translocation of Bcl3 and retarded BCC growth.